Specialty Pharmaceutical Market Report

Europe Specialty Pharmaceutical Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 25, 2019
  • PAGES：162
  • REPORT CODE：GMM393754
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Specialty Pharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Specialty Pharmaceutical Market Segmentations:

    By Player:

    • Gilead Sciences

    • Alcon

    • King Pharmaceutical

    • Pfizer

    • Ajanta Pharma Limited.

    • Teva Pharmaceuticals

    • Allergan

    • Merck idec

    • Speciality European Pharma Limited

    • Purdue Pharma

    • Shire

    • Mylan

    • ConturaCipla

    • Teva Pharmaceutical Industries Ltd.

    • Celgene Corporation

    • Lupin Ltd

    • Biogen

    • Bristol Myers Squibb

    • Johnson＆Johnson

    • Johnson & Johnson

    • Mallinckrodt

    • Sun Pharmaceuticals

    By Type:

    • Antibody

    • Hormone

    • Growth Factors

    • Shire

    • Mallinckrodt

    • Forest

    • SEP

    • Tevu Pharma

    • Allergan

    By End-User:

    • Oncology

    • Inflammatory Conditions

    • Multiple Sclerosis

    • Growth Hormone

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Specialty Pharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Specialty Pharmaceutical Market Size and Growth Rate of Antibody from 2014 to 2026

    • 1.3.2 Europe Specialty Pharmaceutical Market Size and Growth Rate of Hormone from 2014 to 2026

    • 1.3.3 Europe Specialty Pharmaceutical Market Size and Growth Rate of Growth Factors from 2014 to 2026

    • 1.3.4 Europe Specialty Pharmaceutical Market Size and Growth Rate of Shire from 2014 to 2026

    • 1.3.5 Europe Specialty Pharmaceutical Market Size and Growth Rate of Mallinckrodt from 2014 to 2026

    • 1.3.6 Europe Specialty Pharmaceutical Market Size and Growth Rate of Forest from 2014 to 2026

    • 1.3.7 Europe Specialty Pharmaceutical Market Size and Growth Rate of SEP from 2014 to 2026

    • 1.3.8 Europe Specialty Pharmaceutical Market Size and Growth Rate of Tevu Pharma from 2014 to 2026

    • 1.3.9 Europe Specialty Pharmaceutical Market Size and Growth Rate of Allergan from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Specialty Pharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Specialty Pharmaceutical Market Size and Growth Rate of Inflammatory Conditions from 2014 to 2026

    • 1.4.3 Europe Specialty Pharmaceutical Market Size and Growth Rate of Multiple Sclerosis from 2014 to 2026

    • 1.4.4 Europe Specialty Pharmaceutical Market Size and Growth Rate of Growth Hormone from 2014 to 2026

    • 1.4.5 Europe Specialty Pharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Specialty Pharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Specialty Pharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Antibody

      • 3.4.2 Market Size and Growth Rate of Hormone

      • 3.4.3 Market Size and Growth Rate of Growth Factors

      • 3.4.4 Market Size and Growth Rate of Shire

      • 3.4.5 Market Size and Growth Rate of Mallinckrodt

      • 3.4.6 Market Size and Growth Rate of Forest

      • 3.4.7 Market Size and Growth Rate of SEP

      • 3.4.8 Market Size and Growth Rate of Tevu Pharma

      • 3.4.9 Market Size and Growth Rate of Allergan

    4 Segmentation of Specialty Pharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Specialty Pharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Specialty Pharmaceutical for Oncology

      • 4.4.2 Market Size and Growth Rate of Specialty Pharmaceutical for Inflammatory Conditions

      • 4.4.3 Market Size and Growth Rate of Specialty Pharmaceutical for Multiple Sclerosis

      • 4.4.4 Market Size and Growth Rate of Specialty Pharmaceutical for Growth Hormone

      • 4.4.5 Market Size and Growth Rate of Specialty Pharmaceutical for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Specialty Pharmaceutical Production Analysis by Top Regions

    • 5.2 Europe Specialty Pharmaceutical Consumption Analysis by Top Regions

    • 5.3 Europe Specialty Pharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 France Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Circulation of Specialty Pharmaceutical Market among Top Countries

    • 6.1 Top 5 Export Countries in Specialty Pharmaceutical Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Specialty Pharmaceutical Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Specialty Pharmaceutical Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Specialty Pharmaceutical Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Specialty Pharmaceutical Landscape Analysis

    • 7.1 Germany Specialty Pharmaceutical Landscape Analysis by Major Types

    • 7.2 Germany Specialty Pharmaceutical Landscape Analysis by Major End-Users

    8. UK Specialty Pharmaceutical Landscape Analysis

    • 8.1 UK Specialty Pharmaceutical Landscape Analysis by Major Types

    • 8.2 UK Specialty Pharmaceutical Landscape Analysis by Major End-Users

    9. France Specialty Pharmaceutical Landscape Analysis

    • 9.1 France Specialty Pharmaceutical Landscape Analysis by Major Types

    • 9.2 France Specialty Pharmaceutical Landscape Analysis by Major End-Users

    10. Italy Specialty Pharmaceutical Landscape Analysis

    • 10.1 Italy Specialty Pharmaceutical Landscape Analysis by Major Types

    • 10.2 Italy Specialty Pharmaceutical Landscape Analysis by Major End-Users

    11. Spain Specialty Pharmaceutical Landscape Analysis

    • 11.1 Spain Specialty Pharmaceutical Landscape Analysis by Major Types

    • 11.2 Spain Specialty Pharmaceutical Landscape Analysis by Major End-Users

    12. Poland Specialty Pharmaceutical Landscape Analysis

    • 12.1 Poland Specialty Pharmaceutical Landscape Analysis by Major Types

    • 12.2 Poland Specialty Pharmaceutical Landscape Analysis by Major End-Users

    13. Russia Specialty Pharmaceutical Landscape Analysis

    • 13.1 Russia Specialty Pharmaceutical Landscape Analysis by Major Types

    • 13.2 Russia Specialty Pharmaceutical Landscape Analysis by Major End-Users

    14. Switzerland Specialty Pharmaceutical Landscape Analysis

    • 14.1 Switzerland Specialty Pharmaceutical Landscape Analysis by Major Types

    • 14.2 Switzerland Specialty Pharmaceutical Landscape Analysis by Major End-Users

    15. Turkey Specialty Pharmaceutical Landscape Analysis

    • 15.1 Turkey Specialty Pharmaceutical Landscape Analysis by Major Types

    • 15.2 Turkey Specialty Pharmaceutical Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Landscape Analysis by Top Countries

      • 16.3.1 Denmark Specialty Pharmaceutical Market Volume and Growth Rate

      • 16.3.2 Finland Specialty Pharmaceutical Market Volume and Growth Rate

      • 16.3.3 Norway Specialty Pharmaceutical Market Volume and Growth Rate

      • 16.3.4 Sweden Specialty Pharmaceutical Market Volume and Growth Rate

      • 16.3.6 Iceland Specialty Pharmaceutical Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Landscape Analysis by Top Countries

      • 17.3.1 Belgium Specialty Pharmaceutical Market Volume and Growth Rate

      • 17.3.2 Netherlands Specialty Pharmaceutical Market Volume and Growth Rate

      • 17.3.3 Luxembourg Specialty Pharmaceutical Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Landscape Analysis by Top Countries

      • 18.3.1 Estonia Specialty Pharmaceutical Market Volume and Growth Rate

      • 18.3.2 Latvia Specialty Pharmaceutical Market Volume and Growth Rate

      • 18.3.3 Lithuania Specialty Pharmaceutical Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Gilead Sciences

      • 19.1.1 Gilead Sciences Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Alcon

      • 19.2.1 Alcon Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 King Pharmaceutical

      • 19.3.1 King Pharmaceutical Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pfizer

      • 19.4.1 Pfizer Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Ajanta Pharma Limited.

      • 19.5.1 Ajanta Pharma Limited. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Teva Pharmaceuticals

      • 19.6.1 Teva Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Allergan

      • 19.7.1 Allergan Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Merck idec

      • 19.8.1 Merck idec Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Speciality European Pharma Limited

      • 19.9.1 Speciality European Pharma Limited Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Purdue Pharma

      • 19.10.1 Purdue Pharma Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Shire

      • 19.11.1 Shire Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Mylan

      • 19.12.1 Mylan Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 ConturaCipla

      • 19.13.1 ConturaCipla Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Teva Pharmaceutical Industries Ltd.

      • 19.14.1 Teva Pharmaceutical Industries Ltd. Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Celgene Corporation

      • 19.15.1 Celgene Corporation Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Lupin Ltd

      • 19.16.1 Lupin Ltd Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Biogen

      • 19.17.1 Biogen Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Bristol Myers Squibb

      • 19.18.1 Bristol Myers Squibb Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Johnson＆Johnson

      • 19.19.1 Johnson＆Johnson Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Johnson & Johnson

      • 19.20.1 Johnson & Johnson Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Mallinckrodt

      • 19.21.1 Mallinckrodt Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Sun Pharmaceuticals

      • 19.22.1 Sun Pharmaceuticals Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    The List of Tables and Figures (Totals 71 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Antibody from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Hormone from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Growth Factors from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Shire from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Mallinckrodt from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Forest from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of SEP from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Tevu Pharma from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Allergan from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Inflammatory Conditions from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Multiple Sclerosis from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Growth Hormone from 2014 to 2026

    • Figure Europe Specialty Pharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure UK Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure France Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Specialty Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Specialty Pharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Specialty Pharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Specialty Pharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Specialty Pharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Antibody

    • Figure Market Size and Growth Rate of Hormone

    • Figure Market Size and Growth Rate of Growth Factors

    • Figure Market Size and Growth Rate of Shire

    • Figure Market Size and Growth Rate of Mallinckrodt

    • Figure Market Size and Growth Rate of Forest

    • Figure Market Size and Growth Rate of SEP

    • Figure Market Size and Growth Rate of Tevu Pharma

    • Figure Market Size and Growth Rate of Allergan

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Specialty Pharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Specialty Pharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Inflammatory Conditions

    • Figure Market Size and Growth Rate of Multiple Sclerosis

    • Figure Market Size and Growth Rate of Growth Hormone

    • Figure Market Size and Growth Rate of Other

    • Table Europe Specialty Pharmaceutical Production by Major Regions

    • Table Europe Specialty Pharmaceutical Production Share by Major Regions

    • Figure Europe Specialty Pharmaceutical Production Share by Major Countries and Regions in 2014

    • Table Europe Specialty Pharmaceutical Consumption by Major Regions

    • Table Europe Specialty Pharmaceutical Consumption Share by Major Regions

    • Table Germany Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table UK Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table France Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Italy Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Spain Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Poland Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Russia Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Switzerland Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Turkey Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Specialty Pharmaceutical Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Germany Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Germany Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Germany Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table UK Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table UK Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table UK Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table UK Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table France Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table France Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table France Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table France Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Italy Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Italy Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Italy Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Italy Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Spain Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Spain Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Spain Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Spain Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Poland Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Poland Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Poland Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Poland Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Russia Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Russia Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Russia Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Russia Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Switzerland Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Switzerland Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Switzerland Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Turkey Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Turkey Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Turkey Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Specialty Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Specialty Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Specialty Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Specialty Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Gilead Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

    • Figure Sales and Growth Rate Analysis of Gilead Sciences

    • Figure Revenue and Market Share Analysis of Gilead Sciences

    • Table Product and Service Introduction of Gilead Sciences

    • Table Company Profile and Development Status of Alcon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcon

    • Figure Sales and Growth Rate Analysis of Alcon

    • Figure Revenue and Market Share Analysis of Alcon

    • Table Product and Service Introduction of Alcon

    • Table Company Profile and Development Status of King Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of King Pharmaceutical

    • Figure Sales and Growth Rate Analysis of King Pharmaceutical

    • Figure Revenue and Market Share Analysis of King Pharmaceutical

    • Table Product and Service Introduction of King Pharmaceutical

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Ajanta Pharma Limited.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ajanta Pharma Limited.

    • Figure Sales and Growth Rate Analysis of Ajanta Pharma Limited.

    • Figure Revenue and Market Share Analysis of Ajanta Pharma Limited.

    • Table Product and Service Introduction of Ajanta Pharma Limited.

    • Table Company Profile and Development Status of Teva Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals

    • Table Product and Service Introduction of Teva Pharmaceuticals

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Merck idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck idec

    • Figure Sales and Growth Rate Analysis of Merck idec

    • Figure Revenue and Market Share Analysis of Merck idec

    • Table Product and Service Introduction of Merck idec

    • Table Company Profile and Development Status of Speciality European Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Speciality European Pharma Limited

    • Figure Sales and Growth Rate Analysis of Speciality European Pharma Limited

    • Figure Revenue and Market Share Analysis of Speciality European Pharma Limited

    • Table Product and Service Introduction of Speciality European Pharma Limited

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of ConturaCipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ConturaCipla

    • Figure Sales and Growth Rate Analysis of ConturaCipla

    • Figure Revenue and Market Share Analysis of ConturaCipla

    • Table Product and Service Introduction of ConturaCipla

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd.

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd.

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd.

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd.

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Lupin Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin Ltd

    • Figure Sales and Growth Rate Analysis of Lupin Ltd

    • Figure Revenue and Market Share Analysis of Lupin Ltd

    • Table Product and Service Introduction of Lupin Ltd

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of Bristol Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol Myers Squibb

    • Table Product and Service Introduction of Bristol Myers Squibb

    • Table Company Profile and Development Status of Johnson＆Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson＆Johnson

    • Figure Sales and Growth Rate Analysis of Johnson＆Johnson

    • Figure Revenue and Market Share Analysis of Johnson＆Johnson

    • Table Product and Service Introduction of Johnson＆Johnson

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Sun Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sun Pharmaceuticals

    • Table Product and Service Introduction of Sun Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US